Trial reportAmerican journal of hematology2022
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Abstract readClinical TrialLetter
In one paragraph
Trial report in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4Journal of cellular and molecular medicine · 2023Trial
- Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study.Haematologica · 2025Article
- COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.Orphanet journal of rare diseases · 2025Article
- Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.EClinicalMedicine · 2024Article
- COVID-19 and β-thalassemia: in lieu of evidence and vague nexus.Annals of hematology · 2024Review
- Absence of blood donors' anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients.Annals of hematology · 2024Article
- Nephrological Complications in Hemoglobinopathies: SITE Good Practice.Journal of clinical medicine · 2023Article
- Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study.EClinicalMedicine · 2023Article
- Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.Mediterranean journal of hematology and infectious diseases · 2023Article
- Article
- Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.Mediterranean journal of hematology and infectious diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
54 authors.
Filomena LongoAOU San Luigi Gonzaga, Orbassano, Italy.ORCID 0000-0002-0434-0382
Barbara GianesinForAnemia Foundation, Genoa, Italy.
Vincenzo VoiAOU San Luigi Gonzaga, Orbassano, Italy.
Irene MottaDipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-5701-599X
Valeria Maria PintoE.O. Ospedali Galliera, Centro della Microcitemia e delle Anemie Congenite, Genoa, Italy.
Andrea PiolattoAOU San Luigi Gonzaga, Orbassano, Italy.
Anna SpasianoAORN Cardarelli, Naples, Italy.
Giovan Battista RuffoARNAS Civico Di Cristina Benfratelli, Palermo, Italy.
Maria Rita GamberiniAzienda Ospedaliero-Universitaria S.Anna di Ferrara, Ferrara, Italy.
Susanna BarellaSSS Talassemia Ospedale Pediatrico Microcitemico A. Cao, Cagliari, Italy.
Raffaella MarianiUniversity of Milano Bicocca, ASST-Monza, S. Gerardo Hospital, Monza, Italy.
Carmelo FidoneGiovanni Paolo II, Ragusa, Italy.
Rosamaria RossoAOU Policlinico "Vittorio Emanuele", Catania, Italy.
Maddalena CasaleAOU Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.ORCID 0000-0003-4740-2421
Domenico RobertiAOU Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Chiara Dal ZottoPoliclinico GB Rossi, Verona, Italy.
Angelantonio VitucciUOC Ematologia Az. Osp. Univ. Policlinico Bari, Bari, Italy.
Federico BonettiFondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Lorella PitroloA.O.R. Villa Sofia-V. Cervello, Palermo, Italy.
Micol QuaresimaArcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Michela RibersaniPoliclinico Umberto I, Rome, Italy.
Alessandra QuotaUOS Talassemia P.O. Vittorio Emanuele, Gela, Italy.
Francesco ArcioniAzienda Ospedaliera Perugia, Perugia, Italy.
Saveria CampisiPP.OO. Siracusa, Siracusa, Italy.
Antonella MassaGiovanni Paolo II, Olbia, Italy.
Elisa De MicheleAOU OO.RR. San Giovanni Di Dio Ruggi D'Aragona, Salerno, Italy.
Roberto LisiAzienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy.
Maurizio MianoIstituto Giannina Gaslini, Genoa, Italy.
Sabrina BagnatoP.O. Lentini, Siracusa, Italy.
Massimo GentileAzienda ospedaliera di Cosenza, Cosenza, Italy.ORCID 0000-0002-5256-0726
Valentina CarraiAzienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Maria Caterina PuttiAzienda Ospedale Università Padova, Padua, Italy.
Marilena SerraOspedale Vato Vizzi, Lecce, Italy.
Carmen GagliotiAOU San Luigi Gonzaga, Orbassano, Italy.
Margerita Migone De AmicisFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giovanna GraziadeiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-6801-5730
Anna De GiovanniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Paolo RicchiAORN Cardarelli, Naples, Italy.
Manuela BaloccoE.O. Ospedali Galliera, Centro della Microcitemia e delle Anemie Congenite, Genoa, Italy.
Sabrina QuintinoE.O. Ospedali Galliera, Centro della Microcitemia e delle Anemie Congenite, Genoa, Italy.
Zelia BorsellinoARNAS Civico Di Cristina Benfratelli, Palermo, Italy.
Monica FortiniAzienda Ospedaliero-Universitaria S.Anna di Ferrara, Ferrara, Italy.
Anna Rita DenottiSSS Talassemia Ospedale Pediatrico Microcitemico A. Cao, Cagliari, Italy.
Immacolata TartaglioneAOU Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.ORCID 0000-0003-1278-2372
Andrea BeccariaIstituto Giannina Gaslini, Genoa, Italy.
Marco MarzialiPoliclinico Umberto I, Rome, Italy.
Aurelio MaggioA.O.R. Villa Sofia-V. Cervello, Palermo, Italy.
Silverio PerrottaAOU Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Alberto PipernoUniversity of Milano Bicocca, ASST-Monza, S. Gerardo Hospital, Monza, Italy.
Aldo FilosaAORN Cardarelli, Naples, Italy.
Maria Domenica CappelliniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0001-8676-6864
Lucia De FranceschiPoliclinico GB Rossi, Verona, Italy.ORCID 0000-0001-7093-777X
Antonio PigaDepartment of Clinical and Biological Sciences, University of Torino, Turin, Italy.
Gian Luca ForniE.O. Ospedali Galliera, Centro della Microcitemia e delle Anemie Congenite, Genoa, Italy.ORCID 0000-0001-9833-1016
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAged, 80 and overAge FactorsCOVID-19FemaleHemoglobinopathiesHumansItalyMaleMiddle AgedPrevalenceRisk FactorsSARS-CoV-2ThalassemiaYoung Adult
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.